Individualization of anticancer therapy; molecular targets of novel drugs in oncology

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

Deregulation of cellular signal transduction, caused by gene mutations, has been recognized as a basic factor of cancer initiation, promotion and progression. Thus, the ability to control the activity of overstimulated signal molecules by the use of appropriate inhibitors became the idea of targeted cancer therapy, which has provided an effective tool to normalize the molecular disorders in malignant cells and to treat certain types of cancer. The molecularly targeted drugs are divided into two major pharmaceutical classes: monoclonal antibodies and small-molecule kinase inhibitors. This review presents a summary of their characteristics, analyzing their chemical structures, specified molecular targets, mechanisms of action and indications for use. Also the molecules subjected to preclinical trials or phase I, II and III clinical trials evaluating their efficiency and safety are presented. Moreover, the article discusses further perspectives for development of targeted therapies focusing on three major directions: systematic searching and discovery of new targets that are oncogenic drivers, improving the pharmacological properties of currently known drugs, and developing strategies to overcome drug resistance. Finally, the role of proper pharmacodiagnostics as a key to rational anticancer therapy has been emphasized since the verification of reliable predictive biomarkers is a basis of individualized medicine in oncology.

Authors and Affiliations

Katarzyna Regulska, Beata Stanisz, Miłosz Regulski

Keywords

Related Articles

The role of the cannabinoid system in the pathogenesis and treatment of alcohol dependence

The lack of satisfactory results of alcohol dependence treatment force us to search for new directions of research. Recent studies concentrate on endocannabinoid transmission. The results show an interplay between the en...

Wpływ diety suplementowanej tyroksyną na wybrane wykładniki równowagi redox, morfologię wątroby i profil lipidowy szczurów poddanych działaniu doksorubicyny

Wprowadzenie: Cytotoksyczność doksorubicyny (DOX) – leku przeciwnowotworowego, jest w głównej mierze wynikiem generowania reaktywnych form tlenu (RFT). Niektóre z enzymów katalizujących tę reakcję, a także enzymów obrony...

Pies jako model do badań porównawczych nad ludzkimi chłoniakami i białaczkami

Pies towarzyszy człowiekowi od tysięcy lat, dzieli z nim środowisko życia i narażony jest na działanie tych samych, co człowiek czynników środowiskowych, takich jak: zanieczyszczenie powietrza, dym nikotynowy czy różnego...

Nowotworowe komórki macierzyste

Teoria istnienia nowotworowych komórek macierzystych (cancer stem cells – CSC) zyskuje coraz większe znaczenie w świecie medycyny. Liczne dowody badań in vivo oraz in vitro wskazują, że to właśnie populacja niezróżnicowa...

Download PDF file
  • EP ID EP66815
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

Katarzyna Regulska, Beata Stanisz, Miłosz Regulski (2012). Individualization of anticancer therapy; molecular targets of novel drugs in oncology. Advances in Hygiene and Experimental Medicine, 66(0), 855-867. https://europub.co.uk/articles/-A-66815